NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
11 hedge funds and large institutions have $205K invested in NeuroMetrix, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.
57% more capital invested
Capital invested by funds: $131K → $205K (+$74.4K)
8% less funds holding
Funds holding: 12 → 11 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$54.6K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$48.5K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$4.43K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$255 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$64 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.16K |
| 2 |
CA
CoreCap Advisors
Southfield,
Michigan
|
-$497 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$38 |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$17 |
NURO Hedge Fund Activity: Q2 2024 in Review
11 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2024, worth a combined $205K — up 57% from $131K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NURO and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $54.6K. The largest seller was UBS Group, exiting entirely with an estimated $9.16K sold.
- 11 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2024, down from 12 in Q1 2024.
- Funds reported $205K of NeuroMetrix, Inc. Common Stock stock for Q2 2024, up 57% quarter-over-quarter.
- 3 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2024 and 4 closed out, a net change of -1 holder.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2024 was Geode Capital Management, an estimated $54.6K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q2 2024 was UBS Group, an estimated $9.16K sold.
Based on aggregated 13F filings for Q2 2024.